TargetTrack | Target Query Results

1 targets match your request

Target ID:MCSG-APC106902
Source Organism
Listeria monocytogenes EGD-e
Target Name
hypothetical protein lmo2764 [Listeria monocytogenes EGD-e]
Target Category
biomedical,community nominated,disease,individual organism
Target Rationale
Structural studies of transcription regulators that are capable of sensing the environment of a mammalian host cell and switching on a number of various virulence factors.
Status
in PDB
Site
MCSG
Site ID
APC106902
Lab List
ANL
Structure available
4HTL
URL
http://kiemlicz.med.virginia.edu/...
Last Update
2012-02-10
Project List
PSI-3
Database References
MCSG: APC106902, GenBank: 16804801


Targets that contain a matching or similar sequence to your query are listed with the best alignments presented at the top. View the Alignment tab to see how closely a target sequence matches your query.

A target containing one or more sequences may have multiple alignments in this tab.

The Summary tab contains target-level information about a target in your search query.

The Sequence tab contains information about all the sequences defined within a target.

Links to additional annotation sources are provided for each protein sequence, as well as derived protein properties and domain annotations.

The Progress tab contains any trial-level data provided for the target.

Trials are ordered by experimental progress, with the most advanced trials listed first.

The protocols used in each trial are listed by experimental type. A green plus sign indicates protocol details specific to that trial can be found in the protocol summary page.

The Summary tab contains target-level information about a target in your search query.

The Sequence tab contains information about all the sequences defined within a target.

Links to additional annotation sources are provided for each protein sequence, as well as derived protein properties and domain annotations.

The Progress tab contains any trial-level data provided for the target.

Trials are ordered by experimental progress, with the most advanced trials listed first.

The protocols used in each trial are listed by experimental type. A green plus sign indicates protocol details specific to that trial can be found in the protocol summary page.